Transitional Cell Carcinoma Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Transitional Cell Carcinoma?
Urothelial carcinoma (transitional carcinoma) begins in the urothelium, the tissue lining some areas of the urinary system. About 90% of bladder cancer cases and 7% of kidney cancer cases, including cancer of the renal pelvis and ureter, are caused by urothelial carcinoma. The symptoms of urothelial carcinoma-induced bladder and kidney cancers are comparable. Their prognoses are similar; these malignancies are easily treated when detected early but frequently return.
How does urothelial carcinoma affect my body?
Urothelial carcinoma affects the bladder and kidneys in various ways. Bladder abnormal urothelial cells can move from the lining to deeper structures, potentially travelling to distant sites such as the liver, lungs, bones, fatty tissues, and lymph nodes. Low-grade bladder cancer is not likely to metastasise, whereas high-grade disease can be lethal and might recur. Urothelial carcinoma in the kidney may progress to develop tumours in the renal pelvis or ureter, which may then extend to other organs. Both diseases, if not treated, may lead to severe implications.
What is the Importance of Timely Treatment?
Transitional cell carcinoma (TCC), also known as urothelial carcinoma, needs to be treated early to enhance prognoses and prevent the cancer from spreading. If diagnosed early, TCC is often successfully treated with less invasive methods, such as localised or transurethral resection. Postponing therapy may make treatment more difficult and reduce survival by giving the cancer time to move to other parts of the body, such as the liver, lungs, or lymph nodes, or grow deeper into the bladder. Early treatment significantly enhances the outlook for individuals with TCC, controls symptoms, and prevents recurrence.
What are the Common Symptoms of Transitional Cell Carcinoma?
Symptoms of urothelial cancer may not be present at once. Usually, the first noticeable sign is blood in the urine. You should consult a healthcare provider if you notice any symptoms, including blood in the urine.
- Chronic pain in the back.
- Fatigue.
- Unexplained weight loss.
- Dysuria is painful urination.
- Tumour or lump near your kidneys.
- Low-grade fever.
Causes and Risk Factors of Transitional Cell Carcinoma
Causes
The exact aetiology of urothelial carcinoma in the kidneys and bladder is not known to medical scientists. They have found, however, a few common risk factors:
- Cigarette smoke: Smoking cigarettes increases the risk of urothelial carcinoma-related urinary system malignancies.
- Exposuretocertainchemicals: Studies show that individuals who work with chemicals used in paint, leather, rubber, dyes, certain fabrics, and hair care products are at increased risk for urinary system malignancies linked to urothelial carcinoma.
Risk Factors
Some risks of transitional cell carcinoma are mentioned below:
- Smoking
- Exposure to chemicals
- Family history
- Genetic factors
Connect with our advisor for a PRIORITY response
Transitional Cell Carcinoma Prevention Tips
Although there is no guaranteed method to prevent Transitional Cell Carcinoma (TCC), the most important things you can do to lower your risk are to stop smoking, limit your exposure to certain chemicals at work, drink lots of water, and eat a diet high in fruits and vegetables.
Treatment options for Transitional Cell Carcinoma
Surgery is the primary treatment for localised TCC. This includes partial nephrectomy for kidney tumours and transurethral resection for bladder tumours. In certain situations, a radical cystectomy (removal of the bladder) or nephrectomy (removal of the kidney) may be necessary.
Chemotherapy: isfrequently used to eradicate any cancer cells that remain after surgery or for advanced TCC. Chemotherapy is administered intravenously or directly into the bladder for superficial bladder tumours.
Cost Start From USD 600 - USD 700Explore Options
Immunotherapy: Pembrolizumab and other immune checkpoint inhibitors are used more frequently, particularly for advanced or metastatic TCC, since they aid the immune system in recognising and combating cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Radiation therapy is used to decrease tumours before surgery, particularly for bladder TCC, or to treat tumours in locations that are challenging for surgery to reach.
Targeted Therapy: Medications that attack cancer cells specifically based on genetic mutations or tumor-specific proteins are applied in targeted therapy for urothelial carcinoma. The medications can block the signals through which cancer cells grow and disseminate.
Cost Start From USD 8000 - USD 12000Explore Options
Urinalysis: A test to determine the colour of your urine and its components, including germs, blood, protein, and sugar.
Urine cytology: Medical professionals use a microscope to look for abnormal cells in your urine. Cancer cells may leak into your urine if you have cancer in your kidneys, bladder, or ureter.
An intravenous pyelogram (IVP) is a sequence of X-rays of the kidneys, ureter, and bladder to screen for malignancy. Medical professionals inject a contrast dye into one of the veins. To check for obstructions, physicians take X-rays as the dye passes through the kidneys, ureter, and bladder.
Ureteroscopy: To view the ureter and renal pelvis and acquire tissue samples, healthcare professionals use a narrow, tube-like device with a light and viewing lens.
Computed tomography (CT) scans provide detailed images of your internal organs by connecting a computer to an X-ray machine. Computerised tomography or computerised axial tomography are other names for this process.
Ultrasound: A process that creates echoes by reflecting high-energy sound waves off of inside organs or tissues. A sonogram is an image of bodily tissues produced by the echoes. Medical professionals may perform an abdominal ultrasound to help in the diagnosis of renal pelvic and ureter cancer.
Magnetic resonance imaging (MRI) involves creating finely detailed images of body parts, such as the pelvis, using a magnet, radio waves, and a computer. Nuclear magnetic resonance imaging (NMRI) is another name for this process.
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support Transitional cell Carcinoma patients in India. These services include:
- Physical therapy enhances strength, endurance, and mobility after chemotherapy or surgery.
- Occupational therapy: Helping the patient return to usual work and activities, especially after invasive treatment such as surgery or chemotherapy.
- Depending on the situation, your healthcare professional may prescribe medicine to help control your symptoms and support the treatment plan.
Instantly Connect with our Specialists
Hospitals for Transitional Cell Carcinoma in India
Millennium Cancer Center
Gurgaon, India
Millennium Cancer Center is a first of its kind medical center for the research & treatment of cancer in India. The center aims at promoting a knowledge-based cancer care system backed with the latest cancer screening and treatment technology. It provides affordable, accurate, and accessible healthcare to all groups of the society. The hospital has an excellent team of doctors with amazing services, unique infrastructure of international standards in services.
Infrastructure & Facilities:
- Dedicated OPD chambers, Neutropenica Care, and BMT Unit
- Fully equipped intensive care units with the latest monitoring & therapeutic facilities
- In-house 24 X7 blood bank
- All types of in-patient accommodation
- Dedicated neutropenia/leukemia to the special needs of patients
- Hi-tech operation theaters
- Outpatient Chemotherapy Suite to ensure comfort to patients
- An excellent day care cancer centre with state of the art facilities
- Robust IT infrastructure
- State-of-the-art equipped modular operation theatres
- Critical care units equipped with advanced patient monitoring devices, ventilators, isolation rooms
Max Super Speciality Hospital, Patparganj
Delhi, India
Max Super Speciality Hospital, Patparganj, a 400+ bed NABH-accredited facility under Balaji Medical and Diagnostic Research Centre, offers world-class care across 33+ specialties, including Cardiac Sciences, Oncology, Neurosciences, Orthopaedics, Obstetrics & Gynaecology, and Kidney Transplant. With 116 ICU beds, 14 HDU beds, 11 modular OTs, and an NABL-accredited Max Lab, the hospital ensures advanced, quality-driven care. Staffed by 510+ expert doctors and 770+ nurses, it’s India’s first AACI-accredited super speciality hospital and North & West India’s first QAI-accredited Advanced Brain Stroke Centre. Max Patparganj is a regional leader in complex surgeries, blending cutting-edge technology with compassionate, patient-centric healthcare.
Marengo Asia Hospitals, Faridabad
Faridabad, India
Marengo Asia Hospitals, located in Faridabad, is a multispecialty, state-of-the-art, and patient-friendly facility that combines the greatest services available in the healthcare segment. With 325 beds now, the hospital can accommodate up to 550 beds. It has first-rate medical facilities including a Critical Care Medicine department for patients with life-threatening conditions. Furthermore, our highly skilled medical staff and cutting-edge software system make us the perfect facility for patients from various backgrounds. We always aim to exceed expectations and are always looking for ways to boost our performance.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Transitional Cell Carcinoma Treatment?
India is an excellent place for transitional cell carcinoma treatment because of its top-notch medical facilities, qualified oncologists, and best-in-class treatment facilities at reasonable prices. The nation has the latest technology-equipped state-of-the-art hospitals to facilitate effective diagnosis and treatment. Indian hospitals are also internationally accredited, offering high-quality care.
Frequently Asked Questions
Early-stage TCC kidney carcinoma may have over 90% survival, as the National Carcinoma Institute (NCI) reported. The survival rate may be 15% or below if the TCC has progressed past the bladder's inner lining or to other body parts.
The diagnosis of Transitional Cell Carcinoma, or TCC, is more prevalent among older individuals, particularly in India, who are over the age of 55. It is more prevalent among men compared to women. With age, the risk increases due to factors such as prolonged exposure to carcinogens (such as nicotine and industrial chemicals) and the additive effects of long-standing renal or bladder diseases.
Since smoking is one of the substantial risk factors for bladder, kidney, and ureter cancers, it plays a significant role in developing Transitional Cell Carcinoma (TCC) in India. Aromatic amines and various carcinogens present in tobacco smoke are absorbed into the bloodstream, filtered through the kidneys, and finally excreted in urine. These compounds can damage healthy urinary tract cells, causing mutations and the development of TCC. In India, smoking is believed to increase an individual's risk of developing TCC by as much as three times for both genders. It is one of the country's leading preventable causes of TCC.
In India, transitional cell carcinoma (TCC), especially of the bladder and ureters, can recur after treatment. TCC is a high-recurrence tumour, especially in superficial or early-stage cases, even after successful initial treatment, e.g., surgery or chemotherapy.
Regular follow-up with imaging, urine examination, and cystoscopy is mandatory to detect any recurrence at an early stage. Recurrence may be more aggressive and more challenging to manage in advanced cases. To manage the risk of recurrence, Indian patients are advised to undergo therapy and monitoring on a routine basis.
In India, radiation therapy is used to cure Transitional Cell Carcinoma (TCC) in cases where the tumour is incurable or advanced. It is also commonly used to cure bladder cancer, either alone or as a means to destroy cancer cells that remain even after surgery.
Radiation therapy can be combined with chemotherapy for better results. However, due to anatomical challenges, its use is limited to TCC, which aims to decrease symptoms, reduce tumours, and improve the overall quality of life.
Lifestyle and dietary changes can improve overall health and treatment outcomes for TCC patients in India. Some recommendations include
- Drinking plenty of water to help remove toxins and reduce the risk of recurrence.
- Consuming a diet rich in whole grains, fruits, and vegetables to enhance overall health and immunity.
- Reducing the risk of cancer by eating less processed food and red meat.
- Decreasing alcohol intake and smoking can enhance the recovery process and reduce the risk of cancer development.
- Maintaining an active lifestyle to cope with stress, build strength, and reduce fatigue.
- Enhancing mental well-being during treatment through taking part in stress-relieving activities such as yoga or meditation.